Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
1.
Mem Inst Oswaldo Cruz ; 107(5): 652-8, 2012 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-22850956

RESUMEN

Age-related seroprevalence studies that have been conducted in Brazil have indicated a transition from a high to a medium endemicity of hepatitis A virus (HAV) infection in the population. However, most of these studies have focused on urban populations that experience lower incidence rates of HAV infection. In the current study, the prevalence of anti-HAV antibodies was investigated in children with a low socioeconomic status (SES) that live on the periphery of three capital cities in Brazil. A total of 1,162 dried blood spot samples were collected from individuals whose ages ranged from one-18 years and tested for anti-HAV antibodies. A large number of children under five years old (74.1-90%) were identified to be susceptible to HAV infection. The anti-HAV antibody prevalence reached ≥ 50% among those that were 10-14 years of age or older. The anti-HAV prevalence rates observed were characteristics of regions with intermediate level of hepatitis A endemicity. These data indicated that a large proportion of children with a low SES that live at the periphery of urban cities might be at risk of contracting an HAV infection. The hepatitis A vaccine that is currently offered in Brazil is only available for high-risk groups or at private clinics and is unaffordable for individuals with a lower SES. The results from this study suggest that the hepatitis A vaccine should be included in the Brazilian National Program for Immunisation.


Asunto(s)
Anticuerpos de Hepatitis A/sangre , Vacunas contra la Hepatitis A , Virus de la Hepatitis A Humana/inmunología , Hepatitis A/epidemiología , Adolescente , Distribución por Edad , Brasil/epidemiología , Niño , Preescolar , Estudios Transversales , Femenino , Hepatitis A/prevención & control , Humanos , Lactante , Masculino , Prevalencia , Estudios Seroepidemiológicos , Factores Socioeconómicos , Población Urbana
2.
Abdom Radiol (NY) ; 45(2): 479-490, 2020 02.
Artículo en Inglés | MEDLINE | ID: mdl-31616962

RESUMEN

Pancreas transplantation is considered the curative treatment for severe type 1 diabetes mellitus in selected cases. Since the first procedure in 1966, surgical techniques have been improved. The current trend among most medical centers, as well as at our Institution, is enteric drainage and systemic venous or portal anastomosis. The aim of this pictorial essay is to describe the main imaging features of pancreatic transplantation with duodenoduodenostomy drainage.


Asunto(s)
Diabetes Mellitus Tipo 1/cirugía , Duodenostomía , Trasplante de Páncreas , Drenaje/métodos , Humanos , Complicaciones Posoperatorias , Pronóstico
3.
Mem. Inst. Oswaldo Cruz ; 107(5): 652-658, Aug. 2012. ilus, tab
Artículo en Inglés | LILACS | ID: lil-643751

RESUMEN

Age-related seroprevalence studies that have been conducted in Brazil have indicated a transition from a high to a medium endemicity of hepatitis A virus (HAV) infection in the population. However, most of these studies have focused on urban populations that experience lower incidence rates of HAV infection. In the current study, the prevalence of anti-HAV antibodies was investigated in children with a low socioeconomic status (SES) that live on the periphery of three capital cities in Brazil. A total of 1,162 dried blood spot samples were collected from individuals whose ages ranged from one-18 years and tested for anti-HAV antibodies. A large number of children under five years old (74.1-90%) were identified to be susceptible to HAV infection. The anti-HAV antibody prevalence reached ≥ 50% among those that were 10-14 years of age or older. The anti-HAV prevalence rates observed were characteristics of regions with intermediate level of hepatitis A endemicity. These data indicated that a large proportion of children with a low SES that live at the periphery of urban cities might be at risk of contracting an HAV infection. The hepatitis A vaccine that is currently offered in Brazil is only available for high-risk groups or at private clinics and is unaffordable for individuals with a lower SES. The results from this study suggest that the hepatitis A vaccine should be included in the Brazilian National Program for Immunisation.


Asunto(s)
Adolescente , Niño , Preescolar , Femenino , Humanos , Lactante , Masculino , Vacunas contra la Hepatitis A , Anticuerpos de Hepatitis A/sangre , Virus de la Hepatitis A Humana/inmunología , Hepatitis A/epidemiología , Distribución por Edad , Brasil/epidemiología , Estudios Transversales , Hepatitis A/prevención & control , Prevalencia , Estudios Seroepidemiológicos , Factores Socioeconómicos , Población Urbana
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA